サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363789

制吐剤の世界市場規模調査＆予測、薬剤タイプ別、用途別、流通チャネル別、地域別分析、2023-2030年

Global Antiemetics Market Size Study & Forecast, by Drug Type, by Application, by Distribution Channel, and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
制吐剤の世界市場規模調査＆予測、薬剤タイプ別、用途別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年10月04日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

制吐剤の世界市場は2022年に約24億4,000万米ドルと評価され、予測期間2023-2030年には6.1%以上の健全な成長率で成長すると予測されています。

制吐薬は、吐き気や嘔吐を治療または予防するために使用される薬物群であり、多くの異なる医学的疾患、治療、薬物の頻繁な副作用です。制吐薬は、吐き気や嘔吐を軽減する薬の一種です。オピオイド鎮痛薬、全身麻酔薬、化学療法などの副作用の治療に用いられることが多いです。また、乗り物酔い、妊娠、食中毒、めまいなどの患者の症状にも使用されます。吐き気と嘔吐の有病率の増加、研究開発活動の急増と新薬ターゲットの特定、ヘルスケア支出の増加、人々の健康意識の高まり、病院数の増加と相まって、推定期間中の市場成長に関連する主な要因です。

世界のがんと胃腸炎の有病率の増加は、世界中で市場需要を強化する上で重要な役割を果たしています。化学療法と放射線療法は、がんの標準的な治療法です。しかし、これらの治療法はしばしば副作用として重大な吐き気や嘔吐を引き起こします。これらの治療法の採用が増加していることに加え、治療に関連する症状を効果的に管理する必要性が制吐薬の需要を牽引しています。GLOBOCANによると、2020年には世界で約1,930万人の新規がん症例が報告されたと推定され、この数字は2040年までに3,020万人に増加すると予測されています。したがって、これらの前述の要因は、推定期間中に制吐剤市場の成長を推進しています。さらに、ドラッグデリバリーシステムの技術的進歩の高まりや、非腫瘍領域における制吐剤の使用の拡大は、予測期間中に様々な有利な機会をもたらします。しかし、国民の制吐剤に対する認識の低さと適切な動物モデルが入手できないことが、2023-2030年の予測期間を通じて市場成長の課題となっています。

制吐剤の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、化学療法や放射線療法への傾倒の高まり、制吐剤開発の進歩への注目の高まり、定評ある市場プレイヤーの存在により、2022年の市場を独占しました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。老年人口の増加、吐き気と嘔吐の有病率の増加、非オンコロジー環境における制吐剤の使用拡大が、同地域全体の市場需要を大きく促進しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

第2章 世界の制吐剤市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 制吐剤の世界市場力学

  • 制吐剤市場の影響分析（2020-2030年）
    • 市場促進要因
      • がんと胃腸炎の有病率の増加
      • 研究開発活動の急増と新薬ターゲットの特定
    • 市場の課題
      • 制吐剤に対する国民の認識の低さ
      • 適切な動物モデルの不足
    • 市場機会
      • ドラッグデリバリーシステムの技術的進歩の高まり
      • 非腫瘍領域における制吐剤の使用拡大

第4章 世界の制吐薬市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 制吐剤の世界市場：薬剤タイプ別

  • 市場スナップショット
  • 制吐剤の世界市場：薬剤タイプ別、実績 - ポテンシャル分析
  • 医薬品タイプ別制吐剤の世界市場推定・予測：2020-2030年
  • 制吐剤の世界市場、サブセグメント別分析
    • 抗ヒスタミン薬
    • セロトニン受容体拮抗薬
    • ドーパミン受容体拮抗薬
    • ニューロキニン受容体拮抗薬
    • 抗コリン薬
    • その他の薬物タイプ

第6章 制吐剤の世界市場：用途別

  • 市場スナップショット
  • 制吐剤の世界市場：用途別実績-ポテンシャル分析
  • 制吐剤の世界市場：用途別推定・予測2020-2030年
  • 制吐剤の世界市場、サブセグメント別分析
    • 化学療法
    • 手術後
    • 妊娠および腸炎
    • その他の用途

第7章 制吐剤の世界市場：流通チャネル別

  • 市場スナップショット
  • 制吐剤の世界市場：流通チャネル別実績 - ポテンシャル分析
  • 制吐剤の世界市場：流通チャネル別推定・予測2020-2030年
  • 制吐剤の世界市場、サブセグメント別分析
    • 小売薬局
    • 病院薬局
    • オンライン薬局

第8章 制吐剤の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 制吐剤の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 薬剤タイプの推定・予測、2020-2030年
      • 用途別推定・予測、2020～2030年
      • 流通チャネル別の推定・予測、2020～2030年
    • カナダ
  • 欧州制吐剤市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋制吐剤市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの制吐剤市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Novartis AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • GlaxoSmithKline Plc
    • Cipla Limited
    • Acacia Pharma Group Plc
    • Dr. Reddy's Laboratories Ltd
    • Sanofi
    • Merck & Co. Inc
    • Pfizer Inc
    • Torrent Pharmaceuticals Ltd
    • Johnson & Johnson Private Limited

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Antiemetics Market, report scope
  • TABLE 2. Global Antiemetics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Antiemetics Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
  • TABLE 4. Global Antiemetics Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Antiemetics Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Antiemetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Antiemetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Antiemetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Antiemetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Antiemetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Antiemetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Antiemetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Antiemetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Antiemetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Antiemetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Antiemetics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Antiemetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Antiemetics Market
  • TABLE 71. List of primary sources, used in the study of global Antiemetics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Antiemetics Market, research methodology
  • FIG 2. Global Antiemetics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Antiemetics Market, key trends 2022
  • FIG 5. Global Antiemetics Market, growth prospects 2023-2030
  • FIG 6. Global Antiemetics Market, porters 5 force model
  • FIG 7. Global Antiemetics Market, pest analysis
  • FIG 8. Global Antiemetics Market, value chain analysis
  • FIG 9. Global Antiemetics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Antiemetics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Antiemetics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Antiemetics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Antiemetics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Antiemetics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Antiemetics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Antiemetics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Antiemetics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Antiemetics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Antiemetics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Antiemetics Market is valued at approximately USD 2.44 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2023-2030. Antiemetics is a group of drugs used to treat or prevent nausea and vomiting, which are frequent side effects of many different medical illnesses, treatments, and drugs. An antiemetic is a type of medication that lessens nausea and vomiting. The adverse effects of opioid analgesics, general anesthetics, and chemotherapy are frequently treated with them. It is used to treat conditions including motion sickness, pregnancy, food poisoning, and dizziness in patients. The growing prevalence of nausea and vomiting, surge in research and development activities and identification of new drug targets, increasing healthcare expenditure, and rising health consciousness among people, coupled with the rising number of hospitals are the key factors that are associated with the market growth during the estimated period.

The increasing prevalence of cancer and gastroenteritis worldwide is playing a vital role in bolstering the market demand across the globe. Chemotherapy and radiation therapy are standard treatments for cancer. However, these treatments often cause significant nausea and vomiting as side effects. The increasing adoption of these therapies, along with the need to effectively manage treatment-related symptoms, drives the demand for antiemetic medications. The GLOBOCAN stated that, in 2020, it was estimated that approximately 19.3 million new cases of cancer were reported globally and the figure is anticipated to rise to 30.2 million by 2040. Thus, these aforementioned factors are propelling the growth of the Antiemetics Market during the estimated period. Moreover, the rising technological advancements in drug delivery systems, as well as the expanded use of antiemetics in non-oncology settings present various lucrative opportunities over the forecast years. However, the less awareness about antiemetic drugs among the population and the unavailability of suitable animal models are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antiemetics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising inclination towards chemotherapy and radiation therapy, increasing focus on advancements in antiemetic drug development, and the presence of well-established market players. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing geriatric population, increasing prevalence of nausea and vomiting, and expanded use of antiemetics in non-oncology settings are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Novartis AG
  • GlaxoSmithKline Plc
  • Cipla Limited
  • Acacia Pharma Group Plc
  • Dr. Reddy's Laboratories Ltd
  • Sanofi
  • Merck & Co. Inc
  • Pfizer Inc
  • Torrent Pharmaceuticals Ltd
  • Johnson & Johnson Private Limited

Recent Developments in the Market:

  • In February 2020, The US FDA approved Barhemsys from Acacia Pharmaceutical. A formulation of amisulpride (a dopamine antagonist) for intravenous administration is used to treat postoperative nausea and vomiting in individuals who failed to improve after receiving therapy with an antiemetic from a different class. Barhemsys is anticipated to go on sale in the second half of 2022, as the business is already making such preparations.

Global Antiemetics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Type, Application, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

  • Antihistamines
  • Serotonin Receptor Antagonists
  • Dopamine Receptor Antagonists
  • Neurokinin Receptor Antagonists
  • Anticholinergics
  • Other Drug Types

By Application:

  • Chemotherapy
  • Post Operative Surgery
  • Pregnancy and Gatroenteritis
  • Other Applications

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Antiemetics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Antiemetics Market, by Drug Type, 2020-2030 (USD Billion)
    • 1.2.3. Antiemetics Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Antiemetics Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antiemetics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antiemetics Market Dynamics

  • 3.1. Antiemetics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer and gastroenteritis
      • 3.1.1.2. Surge in research and development activities and identification of new drug targets
    • 3.1.2. Market Challenges
      • 3.1.2.1. Less awareness about antiemetic drugs among the population
      • 3.1.2.2. Unavailability of suitable animal model
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising technological advancements in drug delivery systems
      • 3.1.3.2. Expanded use of antiemetics in non-oncology settings

Chapter 4. Global Antiemetics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Antiemetics Market, by Drug Type

  • 5.1. Market Snapshot
  • 5.2. Global Antiemetics Market by Drug Type, Performance - Potential Analysis
  • 5.3. Global Antiemetics Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
  • 5.4. Antiemetics Market, Sub Segment Analysis
    • 5.4.1. Antihistamines
    • 5.4.2. Serotonin Receptor Antagonists
    • 5.4.3. Dopamine Receptor Antagonists
    • 5.4.4. Neurokinin Receptor Antagonists
    • 5.4.5. Anticholinergics
    • 5.4.6. Other Drug Types

Chapter 6. Global Antiemetics Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Antiemetics Market by Application, Performance - Potential Analysis
  • 6.3. Global Antiemetics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Antiemetics Market, Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Post Operative Surgery
    • 6.4.3. Pregnancy and Gatroenteritis
    • 6.4.4. Other Applications

Chapter 7. Global Antiemetics Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Antiemetics Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Antiemetics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Antiemetics Market, Sub Segment Analysis
    • 7.4.1. Retail Pharmacies
    • 7.4.2. Hospital Pharmacies
    • 7.4.3. Online Pharmacies

Chapter 8. Global Antiemetics Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Antiemetics Market, Regional Market Snapshot
  • 8.4. North America Antiemetics Market
    • 8.4.1. U.S. Antiemetics Market
      • 8.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Antiemetics Market
  • 8.5. Europe Antiemetics Market Snapshot
    • 8.5.1. U.K. Antiemetics Market
    • 8.5.2. Germany Antiemetics Market
    • 8.5.3. France Antiemetics Market
    • 8.5.4. Spain Antiemetics Market
    • 8.5.5. Italy Antiemetics Market
    • 8.5.6. Rest of Europe Antiemetics Market
  • 8.6. Asia-Pacific Antiemetics Market Snapshot
    • 8.6.1. China Antiemetics Market
    • 8.6.2. India Antiemetics Market
    • 8.6.3. Japan Antiemetics Market
    • 8.6.4. Australia Antiemetics Market
    • 8.6.5. South Korea Antiemetics Market
    • 8.6.6. Rest of Asia Pacific Antiemetics Market
  • 8.7. Latin America Antiemetics Market Snapshot
    • 8.7.1. Brazil Antiemetics Market
    • 8.7.2. Mexico Antiemetics Market
  • 8.8. Middle East & Africa Antiemetics Market
    • 8.8.1. Saudi Arabia Antiemetics Market
    • 8.8.2. South Africa Antiemetics Market
    • 8.8.3. Rest of Middle East & Africa Antiemetics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Novartis AG
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. GlaxoSmithKline Plc
    • 9.3.3. Cipla Limited
    • 9.3.4. Acacia Pharma Group Plc
    • 9.3.5. Dr. Reddy's Laboratories Ltd
    • 9.3.6. Sanofi
    • 9.3.7. Merck & Co. Inc
    • 9.3.8. Pfizer Inc
    • 9.3.9. Torrent Pharmaceuticals Ltd
    • 9.3.10. Johnson & Johnson Private Limited

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption